Ni Y H, Huo L J, Li T T
The First Hospital of Shanxi Medical University, Taiyuan 030001, China.
Zhonghua Gan Zang Bing Za Zhi. 2017 Jan 20;25(1):9-14. doi: 10.3760/cma.j.issn.1007-3418.2017.01.004.
To investigate the effect of interleukin-22 (IL-22) on the activation and proliferation of hepatic stellate cells (HSCs) induced by acetaldehyde, as well as the role of the antioxidant axis Nrf2-keap1-ARE. Hepatic stellate cell-T6 (HSC-T6) cells were cultured in vitro, and after 24 and 48 hours of acetaldehyde stimulation at various concentrations (25, 50, 100, 200, and 400 μmol/L), MTT assay was used to measure cell proliferation rate to screen out the optimal conditions for model establishment. HSC-T6 cells were treated first with the optimal concentration of acetaldehyde (200 μmol/L) for 24 hours and then with different concentrations of IL-22 (10, 20, and 50 ng/ml) for 24 hours. MTT assay was used to measure cell proliferation, Western blot and cell immunohistochemistry were used to measure the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and α-smooth muscle actin (α-SMA), and spectrophotometry was used to measure the changes in the content of malondialdehyde (MDA) and reduced glutathione (GSH) in culture supernatant. SPSS 17.0 was used for statistical analysis and data were expressed as mean±SD. < 0.05 was considered statistically significant. A one-way analysis of variance was used for comparison of means between any two groups. HSCs had significantly enhanced proliferation and activation after being treated with acetaldehyde, especially at 200 μmol/L for 48 hours. After the intervention with gradient concentrations of IL-22, the proliferation and activation of HSCs were inhibited in a dose-dependent manner, and the proliferation and migration rates in the 10, 20, and 50 ng/ml IL-22 groups were 14%, 25%, and 35%, respectively (all < 0.05). The results of Western blot and immunohistochemistry showed that there was no significant difference in the expression of Nrf2 total protein in HSCs between groups, while there was extremely low expression of Nrf2 nucleoprotein in the blank control group. There was increased expression of Nrf2 nucleoprotein after acetaldehyde stimulation (compared with the blank control group, < 0.05), and after the intervention with gradient concentrations of IL-22, the expression of Nrf2 nucleoprotein was further increased (all < 0.05). The results of spectrophotometry showed that compared with the blank control group, the model group had increased levels of MDA and GSH in culture supernatant after acetaldehyde stimulation; after the intervention with gradient concentrations of IL-22, there was a significant reduction in the MDA level and a significant increase in the GSH level in a dose-dependent manner (all < 0.05). The activation and proliferation of HSCs induced by acetaldehyde helps with the successful establishment of an in vitro model of alcoholic liver fibrosis. IL-22 effectively inhibits the activation and proliferation of HSCs induced by acetaldehyde, and its mechanism may be related to promoting Nrf2 nuclear translocation in HSCs and expression of the downstream target gene GSH and increasing the activity of the antioxidant axis Nrf2-keap1-ARE.
探讨白细胞介素-22(IL-22)对乙醛诱导的肝星状细胞(HSCs)活化和增殖的影响,以及抗氧化轴Nrf2-keap1-ARE的作用。体外培养肝星状细胞-T6(HSC-T6),用不同浓度(25、50、100、200和400μmol/L)的乙醛刺激24和48小时后,采用MTT法检测细胞增殖率以筛选模型建立的最佳条件。先将HSC-T6细胞用最佳浓度的乙醛(200μmol/L)处理24小时,再用不同浓度的IL-22(10、20和50ng/ml)处理24小时。采用MTT法检测细胞增殖,Western印迹法和细胞免疫组织化学法检测核因子红细胞2相关因子2(Nrf2)和α-平滑肌肌动蛋白(α-SMA)的表达,分光光度法检测培养上清液中丙二醛(MDA)和还原型谷胱甘肽(GSH)含量的变化。采用SPSS 17.0进行统计分析,数据以均数±标准差表示。P<0.05认为差异有统计学意义。采用单因素方差分析比较任意两组间的均值。乙醛处理后HSCs的增殖和活化显著增强,尤其是200μmol/L处理48小时。用梯度浓度的IL-22干预后,HSCs的增殖和活化呈剂量依赖性抑制,10、20和50ng/ml IL-22组的增殖和迁移率分别为14%、25%和35%(均P<0.05)。Western印迹法和免疫组织化学结果显示,各组HSCs中Nrf2总蛋白的表达无显著差异,而空白对照组中Nrf2核蛋白的表达极低。乙醛刺激后Nrf2核蛋白表达增加(与空白对照组比较,P<0.05),用梯度浓度的IL-22干预后,Nrf2核蛋白的表达进一步增加(均P<0.05)。分光光度法结果显示,与空白对照组比较,模型组乙醛刺激后培养上清液中MDA和GSH水平升高;用梯度浓度的IL-22干预后,MDA水平显著降低,GSH水平呈剂量依赖性显著升高(均P<0.05)。乙醛诱导的HSCs活化和增殖有助于成功建立酒精性肝纤维化体外模型。IL-22有效抑制乙醛诱导的HSCs活化和增殖,其机制可能与促进HSCs中Nrf2核转位及下游靶基因GSH的表达、增强抗氧化轴Nrf2-keap1-ARE的活性有关。
Zhonghua Gan Zang Bing Za Zhi. 2017-1-20
World J Gastroenterol. 2017-3-21
Zhonghua Gan Zang Bing Za Zhi. 2024-3-20
Zhonghua Gan Zang Bing Za Zhi. 2018-9-20
Zhonghua Gan Zang Bing Za Zhi. 2016-3-20
Zhonghua Gan Zang Bing Za Zhi. 2013-2
World J Gastroenterol. 2023-4-21
Biomedicines. 2021-12-31
Nat Rev Gastroenterol Hepatol. 2018-12
Nat Rev Gastroenterol Hepatol. 2018-7